Cognizant today announced a partnership with Medable Inc. to jointly deliver clinical research solutions based on Medable’s software-as-a-service platform for decentralized clinical trials.

Cognizant will provide Medable with strategic advisory services, technology deployment and best-in-class global support to help Medable customers reduce clinical trial timelines, improve the patient experience, and bring effective therapies to market more quickly. Cognizant and Medable’s collaboration will:

• Help pharma and biotech sponsors assess the feasibility of decentralized clinical trial deployment across their portfolio of clinical studies
• Provide change management and digital training to help pharma and biotech sponsors deploy clinical studies and better manage virtual trials
• Advise on the use of Medable products, and deploy Medable-accredited experts to implement, configure, and integrate the Medable platform for study setup
• Ensure successful management of studies through completion, and assist in insight generation and data analysis
• Support patients during the study through helpdesk, remote monitoring, etc.; and
• Provide operational support to sponsors for their regulatory submissions and safety and pharmacovigilance functions

Medable and Cognizant will work together to advise clients on modern clinical trial deployment requirements, building on Medable’s product portfolio including digital screening, TeleConsent, TeleCOA, TeleVisit, and remote patient monitoring.

“We’re thrilled to partner with Cognizant to empower pharma and biotech teams and accelerate the shift to patient-centric, decentralized clinical trials,” said Dr. MaryAnne Rizk, chief strategy officer at Medable. “Cognizant’s strong life sciences expertise, global implementation resources, and change management capabilities will help ensure that clinical trial sponsors receive best-in-class capabilities to maximize their success.”

“We share Medable’s vision for patient-centric research and clinical improvement, and we’re excited to expand the expert services available for Medable’s industry-leading platform,” said Avi Kulkarni, senior vice president for life sciences R&D at Cognizant. “Working together, we can collaborate with pharma sponsors to transform their clinical research to start up quicker, reduce patient burden, and ultimately bring therapies to market faster.”